TRST - トラストコ・バンク (TrustCo Bank Corp NY)


   TrustCo Bank Corp NY Announces Stock Repurchase Plan  2022/03/09 21:46:00 GlobeNewswire
GLENVILLE, N.Y., March 09, 2022 (GLOBE NEWSWIRE) -- TrustCo Bank Corp NY (TrustCo, Nasdaq: TRST) today announced that its Board of Directors has approved a stock repurchase program. Under the stock repurchase program, TrustCo may repurchase up to 200,000 shares of its common stock, or approximately 1% of its current outstanding shares. The repurchase program will permit shares to be repurchased in open market or private transactions, through block trades, or pursuant to any trading plan that may be adopted in accordance with Rule 10b5-1 of the Securities and Exchange Commission.
   TrustCo Bank Corp NY''s (TRST) CEO Robert McCormick on Q4 2021 Results - Earnings Call Transcript  2022/01/25 19:08:04 Seeking Alpha
   New York State Teachers Retirement System Sells 1,000 Shares of TrustCo Bank Corp NY (NASDAQ:TRST)  2021/12/23 09:24:45 ETF Daily News
New York State Teachers Retirement System lowered its stake in shares of TrustCo Bank Corp NY (NASDAQ:TRST) by 2.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 42,995 shares of the banks stock after selling 1,000 shares during the period. [] The post New York State Teachers Retirement System Sells 1,000 Shares of TrustCo Bank Corp NY (NASDAQ:TRST) appeared first on ETF Daily News .
   Insider Buying: TrustCo Bank Corp NY (NASDAQ:TRST) CEO Purchases $113,400.00 in Stock  2021/12/20 10:38:42 Transcript Daily
TrustCo Bank Corp NY (NASDAQ:TRST) CEO Robert J. Mccormick bought 3,500 shares of TrustCo Bank Corp NY stock in a transaction dated Wednesday, December 15th. The shares were acquired at an average cost of $32.40 per share, with a total value of $113,400.00. The acquisition was disclosed in a legal filing with the Securities & []
   Parametric Portfolio Associates LLC Decreases Stock Holdings in TrustCo Bank Corp NY (NASDAQ:TRST)  2021/12/12 09:54:42 Transcript Daily
Parametric Portfolio Associates LLC decreased its holdings in TrustCo Bank Corp NY (NASDAQ:TRST) by 82.3% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 67,746 shares of the banks stock after selling 314,055 shares during the quarter. Parametric Portfolio Associates LLCs holdings in TrustCo []
   Im struggling to get excited about Trustpilot shares  2021/06/23 14:49:09 The Motley Fool UK
Given its brand and the immediate market opportunity, I probably should be excited. But I just cant get there. The post Im struggling to get excited about Trustpilot shares appeared first on The Motley Fool UK .
   Former CannTrust CEO, directors charged in illegal pot growing case  2021/06/22 19:03:16 National Post
Two former directors and a former chief executive of Canadian cannabis producer CannTrust Holdings Inc have been charged with fraud in connection with an illegal cultivation scandal dating back to 2019, Ontarios markets regulator said on Tuesday. The Ontario Securities Commission (OSC) said former CannTrust CEO Peter Aceto, and former directors Mark Litwin and Eric []
   Former CannTrust executives face securities charges after unlicenced cannabis growing  2021/06/22 15:36:24 Mountain View Gazette
The former chief executive and two past board members of CannTrust Holdings Inc. are facing charges roughly three years after the cannabis company became embroiled in unlicensed growing allegations.
   Three ex-CannTrust execs face charges over illicit cannabis growing - Article - BNN  2021/06/22 14:40:37 BNN Bloomberg
Three former senior directors at CannTrust Holdings Inc. have been charged with several offences following the company''s efforts to conceal the illegal growing of cannabis at the pot producer between 2018 to 2019.
   Former CannTrust execs charged after alleged illegal growing at Ont. facility  2021/06/22 14:03:10 Collingwood Today
VAUGHAN, Ont. Three former directors and officers at cannabis company CannTrust Holdings Inc. have been charged with several offences under the Securities Act.
   Red White & Bloom's Brad Rogers On The Power Of Branding In Cannabis  2021/05/07 14:53:48 Benzinga
During a recent interview with Benzinga, Red White & Bloom Brands Inc.'s (OTCQX: RWBYF ) chairman and CEO Brad Rogers said he and his team are focused on executing the business plan they believe works. "We know our business. We know our plan," the CEO said. The cannabis multistate operator and its several brands aim to focus on the quality of states in which it's involved in rather than the quantity, he said. The vision includes brands like Platinum Vapes, a company RWB acquired in July 2020. Rogers said the line now holds roughly 35% of the Michigan vape market share. The company also has a deal with HighTimes Holding Corp. to create branded products, including unique products for the Michigan market. Rogers said the partnership with High Times helps further bolster RWB's brand presence. Establishing Power Through Branding Rogers served as president and COO of Canntrust Holdings Inc. from 2015 to 2018. With Platinum Vapes, Rogers said he sees entryways into markets that MSOs have traditionally steered clear of like Oklahoma.
   Europe is minting tech unicorns. Moonfire Ventures has raised $60 million to back them early.  2021/05/06 11:31:40 Business Insider
Summary List Placement European venture capitalist Mattias Ljungman hopes to capitalize on the ecosystem's growth spurt with a $60 million fund for his new firm Moonfire Ventures. Ljungman previously cofounded venture capital firm Atomico with Skype billionaire Niklas Zennstrom in 2006, and announced his departure in 2019. At Atomico, he backed Finnish gaming firm Supercell and payments firm Klarna, both multibillion-dollar companies. He now plans to focus on earlier-stage investing with Moonfire Ventures, which he has set up alongside partners Mike Arpaia, a former Facebooker; and Candice Lo, an Uber exec turned investor. Moonfire will mostly write seed checks between $1 million and $1.5 million to founders of startups working in health and wellbeing; work; gaming; leisure, and finance. The fund has already backed gaming startup LoveShark and employee management software firm Humaans. Ljungman told Insider that Moonfire hoped to outperform the competition by making use of data. This is something of a growing trend among venture capital investors, who have traditionally relied on "warm introductions" and existing networks to find new founders to back.
   Housebuilders deleting negative online reviews to boost scores  2021/04/11 04:00:00 The Telegraph
Companies flagging suspicious Trustpilot comments
   Utilizing User Reviews for Unbiased Broker Recommendations  2021/03/29 12:54:30 Benzinga
There is a new trend emerging in the world of online trading. A trend that aims to help traders find the best trading platforms and tools with the help of feedback from other traders. One of the main issues facing new online traders are unserious operators that market and promote unserious brokers solely for monetary profit. Brokers can easily pay for 5-star reviews, and the industry has been struggling to combat this issue. Until now, that is. Spearheaded by sites such as , a handful of broker comparison sites from around the world have started including feedback from real users in their reviews. They do this to establish trust and to encourage transparency, and we believe it's one of the most exciting developments in the industry in recent years. An Innovative Way of Encouraging Unbiasedness By automatically collecting feedback and user ratings from reliable platforms such as Trustpilot, the App Store and Google Play, companies can combine the ratings of millions of users with their in-depth investigations.
   Cannabis Movers & Shakers: Newscope Capital, Mr. Cannabis Law, CannTrust, Nabis, AMMJ, Plus Products, Christina Lake  2021/03/19 18:10:14 Benzinga
Depression Researcher Joins Newscope Capital’s PharmaTher Newscope Capital Corporation (CSE:PHRM) (OTCQB: PHRRF ) has appointed Dr. Maurizio Fava, MD, through its subsidiary PharmaTher Inc., to serve as a scientific and clinical advisor for clinical research initiatives with KETABET, a treatment option for depression. Besides serving as psychiatrist-in-chief at the Massachusetts General Hospital, Fava is also a director at Division of Clinical Research of the MGH Research Institute, executive director of the Clinical Trials Network and Institute, associate dean for clinical and translational research, and the Slater Family Professor of Psychiatry at Harvard Medical School, Psychedelic Finance writes . Fava said Tuesday he is looking forward to collaborating with PharmaTher. “There is a significant unmet medical need for new therapeutics for depression, and ketamine, with its limitations, is an attractive treatment option,” he added. Mr. Cannabis Law Taps New Senior Associate Attorney Cannabis-focused full-service law firm Mr.